Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

BRKH vs HCMA: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

HCMA Wins Head-to-Head Institutional Verdict (2–0 across 6 Pillars · 8–0 Matrix Metrics)

HCMA Overall Winner 6-Pillar Tally: BRKH 0 – 2 HCMA (4 Tie) Matrix Metrics: BRKH 0 – 8 HCMA

As of Nov 20, 2026, HCM III Acquisition Corp. Class A Ordinary Share (HCMA) is the stronger overall head-to-head candidate over BRKH (BRKH) in the Tradestie Institutional Equity Comparison Engine, winning 8–0 core matrix metrics and 2–0 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality). BRKH carries a Unified Composite Score of 59.4/100 (HOLD) at $10.14 (N/M Forward P/E, N/A operating margin), whereas HCMA carries 62.1/100 (BUY) at $10.35 (N/M Forward P/E, 0.0% operating margin).

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About BRKH vs HCMA
BRKH US Equity
BRKH
Institutional Equity
$10.14
+0.8% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol -0.04β · 4% Vol
Unified Composite Score
59.4 / 100 HOLD
Tech 50.0 Fund 50.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Trend telemetry aligned with daily close.
RSI-14: N/A · SMA20: N/A · SMA50: N/A
HCMA NASDAQ Head-to-Head Winner
HCM III Acquisition Corp. Class A Ordinary Share
Blank Checks
$10.35
+0.0% 1D
Market Cap $349.1M
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.02β · 2% Vol
Unified Composite Score
62.1 / 100 BUY
Tech 68.0 Fund 56.0 Flow 50.0 Mom 46.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (0.6% over 20 days), RSI 55
RSI-14: 55.4 · SMA20: $10.29 · SMA50: $10.26

6-Pillar Scorecard Institutional Category Breakdown (BRKH 0 – 2 HCMA)

Columns: Metric · BRKH · HCMA
1. Valuation Multiples Tie
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue N/M N/M
2. Growth & Scale HCMA
Revenue Growth (YoY) N/A +0.0%
Earnings Growth (YoY) N/A +0.0%
TTM Revenue (USD) N/A N/A
Market Cap N/A $349.1M
3. Profitability & Quality HCMA
Gross Margin N/A N/A
Operating Margin N/A 0.0%
Net Profit Margin N/A 0.0%
Return on Equity (ROE) N/A 0.0%
4. Balance Sheet & Cash Flow Tie
Cash Generation (TTM) N/A N/A
Cash Flow Margin N/A N/A
Net Cash / Leverage N/A ROE 0.0% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Markup
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Institutional Equity Operator Shell Companies Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: BRKH (0) vs HCMA (8)
Institutional Metric BRKH HCMA Criterion Row Edge
Market Capitalization
Scale
N/A $349.1M Larger Scale HCMA
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
N/A +0.0% Higher Growth HCMA
Operating Margin (TTM)
Profitability
N/A 0.0% Higher Margin HCMA
Net Profit Margin
Profitability
N/A 0.0% Higher Margin HCMA
Return on Equity (ROE)
Capital Efficiency
N/A 0.0% Higher ROE HCMA
52-Week Range Position
Momentum
27% ($10–$11) 70% ($10–$10) Stronger Trend HCMA
Beta / 30D Volatility
Risk Regime
-0.04β · 4% Vol 0.02β · 2% Vol Lower Realized Risk HCMA
Unified Institutional Score
Composite Signal
59.4 / 100 (HOLD) 62.1 / 100 (BUY) Higher Composite HCMA
Trailing 12M Revenue (USD)
Operating Scale
N/A N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (N/A ROE) N/A (0.0% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon BRKH +1.03 pp
BRKH: +1.71% · HCMA: +0.68%
3M Horizon BRKH +1.83 pp
BRKH: +2.22% · HCMA: +0.39%
6M Horizon BRKH +1.83 pp
BRKH: +2.22% · HCMA: +0.39%
1Y Horizon BRKH +1.83 pp
BRKH: +2.22% · HCMA: +0.39%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BRKH vs HCMA. Trailing 12-month operating profitability (BRKH N/A vs HCMA 0.0%) and valuation multiples (BRKH N/M vs HCMA N/M Forward P/E) are benchmarked directly in Pillar 4 below.

BRKH ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M
HCMA ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. Margin0.0%
ROE / Fwd P/E0.0% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
BRKH UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact BRKH Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
HCMA UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact HCMA Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
BRKH Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
HCMA Moat Profile Cyclical / Execution-Driven Positioning
Shell Companies Operator
Competes within the Shell Companies value chain with $349.1M market capitalization and 0.0% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ BRKH vs HCMA Key Questions & Quantitative Answers

As of Nov 20, 2026, HCM III Acquisition Corp. Class A Ordinary Share (HCMA) is the stronger overall head-to-head candidate over BRKH (BRKH) in the Tradestie Institutional Equity Comparison Engine, winning 8–0 core matrix metrics and 2–0 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality). BRKH carries a Unified Composite Score of 59.4/100 (HOLD) at $10.14 (N/M Forward P/E, N/A operating margin), whereas HCMA carries 62.1/100 (BUY) at $10.35 (N/M Forward P/E, 0.0% operating margin). Technically, BRKH sits in a Neutral phase (RSI N/A, UNCLASSIFIED options structure) and HCMA sits in a Markup phase (RSI 55.4, UNCLASSIFIED options structure).

HCMA leads the Growth & Scale pillar: BRKH posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with HCMA at +0.0% YoY revenue growth and +0.0% YoY earnings growth on N/A TTM revenue (N/A gross margin, 0.0% operating margin). On trailing 12-month operating scale, BRKH generates N/A in USD-normalized revenue versus N/A for HCMA. In operating R&D and SG&A reinvestment, BRKH deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for HCMA.

BRKH and HCMA trade at balanced relative valuation multiples. BRKH trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas HCMA trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against BRKH (N/A ROE) versus HCMA (0.0% ROE) capital efficiency.

In options market volatility and institutional positioning, BRKH carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.04β · 4% Vol realized risk). By comparison, HCMA carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.02β · 2% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.